Home Healthcare Biotechnology Next-Generation Gynecological Cancer Diagnostics Market

Next-Generation Gynecological Cancer Diagnostics Market Size, Share & Trends Analysis Report By Technology (Next generation sequencing, Polymerase chain reaction (PCR), DNA Microarrays, Multiplexing, Protein Microarrays, Others), By Cancer Type (Breast, Lung, Colorectal, Prostate, Cervical, Others), By Function (Cancer Screening, Therapeutic Monitoring, Risk Analysis) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Next-Generation Gynecological Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Next generation sequencing
      2. Polymerase chain reaction (PCR)
      3. DNA Microarrays
      4. Multiplexing
      5. Protein Microarrays
      6. Others
    3. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast
      2. Lung
      3. Colorectal
      4. Prostate
      5. Cervical
      6. Others
    4. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
      1. Cancer Screening
      2. Therapeutic Monitoring
      3. Risk Analysis
  7. North America Next-Generation Gynecological Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Next generation sequencing
      2. Polymerase chain reaction (PCR)
      3. DNA Microarrays
      4. Multiplexing
      5. Protein Microarrays
      6. Others
    3. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast
      2. Lung
      3. Colorectal
      4. Prostate
      5. Cervical
      6. Others
    4. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
      1. Cancer Screening
      2. Therapeutic Monitoring
      3. Risk Analysis
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
  8. Europe Next-Generation Gynecological Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Next generation sequencing
      2. Polymerase chain reaction (PCR)
      3. DNA Microarrays
      4. Multiplexing
      5. Protein Microarrays
      6. Others
    3. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast
      2. Lung
      3. Colorectal
      4. Prostate
      5. Cervical
      6. Others
    4. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
      1. Cancer Screening
      2. Therapeutic Monitoring
      3. Risk Analysis
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    7. France
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
  9. APAC Next-Generation Gynecological Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Next generation sequencing
      2. Polymerase chain reaction (PCR)
      3. DNA Microarrays
      4. Multiplexing
      5. Protein Microarrays
      6. Others
    3. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast
      2. Lung
      3. Colorectal
      4. Prostate
      5. Cervical
      6. Others
    4. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
      1. Cancer Screening
      2. Therapeutic Monitoring
      3. Risk Analysis
    5. China
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    8. India
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
  10. Middle East and Africa Next-Generation Gynecological Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Next generation sequencing
      2. Polymerase chain reaction (PCR)
      3. DNA Microarrays
      4. Multiplexing
      5. Protein Microarrays
      6. Others
    3. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast
      2. Lung
      3. Colorectal
      4. Prostate
      5. Cervical
      6. Others
    4. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
      1. Cancer Screening
      2. Therapeutic Monitoring
      3. Risk Analysis
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
  11. LATAM Next-Generation Gynecological Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Next generation sequencing
      2. Polymerase chain reaction (PCR)
      3. DNA Microarrays
      4. Multiplexing
      5. Protein Microarrays
      6. Others
    3. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast
      2. Lung
      3. Colorectal
      4. Prostate
      5. Cervical
      6. Others
    4. Next-Generation Gynecological Cancer Diagnostics Market Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
      1. Cancer Screening
      2. Therapeutic Monitoring
      3. Risk Analysis
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Next generation sequencing
        2. Polymerase chain reaction (PCR)
        3. DNA Microarrays
        4. Multiplexing
        5. Protein Microarrays
        6. Others
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast
        2. Lung
        3. Colorectal
        4. Prostate
        5. Cervical
        6. Others
      4. Market Size & Forecast By Function 2022-2034 (USD MILLION/ Units)
        1. Cancer Screening
        2. Therapeutic Monitoring
        3. Risk Analysis
  12. Competitive Landscape
    1. Next-Generation Gynecological Cancer Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Johnson & Johnson
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina, Inc.
    3. Novartis AG
    4. Hoffmann-La Roche Ltd
    5. Koninklijke Philips N.V.
    6. QIAGEN
    7. Agilent Technologies, Inc.
    8. Abbott
    9. Thermo Fisher Scientific Inc.
    10. GE HealthCare
    11. Karkinos Healthcare
    12. GenScript
    13. Exact Sciences Corporation
    14. Bio-Rad Laboratories, Inc.
    15. Almac Group
    16. Cepheid
    17. Natera, Inc.
    18. Hologic, Inc.
    19. Sysmex Corporation
    20. PerkinElmer Life Sciences & Diagnostics
    21. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.